Hysteroscopy By GenWorks – A Minimally Invasive Solution For Treating Intrauterine Abnormalities
New Delhi (India), July 28: Women’s reproductive health is a significant and sensitive topic that must be stressed for achieving healthcare accessibility. To ensure that women are exposed to effective and minimally invasive reproductive health procedures, GenWorks focuses on bringing devices designed to get rid of common gynaecological problems to the market. Two of the […]

New Delhi (India), July 28: Women’s reproductive health is a significant and sensitive topic that must be stressed for achieving healthcare accessibility. To ensure that women are exposed to effective and minimally invasive reproductive health procedures, GenWorks focuses on bringing devices designed to get rid of common gynaecological problems to the market. Two of the common reproductive problems called Fibroids and Polyps are known to cause Infertility and Recurrent Pregnancy loss in women. The removal of Polyps improves fertility outcomes through spontaneous conception, IUI, and IVF. GenWorks promotes a minimally invasive solution for treating intrauterine pathology problems such as Fibroids, Polyps, RPOC, and many more.
According to market analysis, the market size of hysteroscopy procedures is valued at USD 3.83 Billion in 2020 and is expected to grow at a CAGR of 6.7% from 2021 to 2028. This figure is reflective of the fact that an increasing number of women are becoming sensitive to ensuring healthy reproductive health. There is a rising prevalence of gynaecological disorders including intrauterine abnormalities worldwide. Abnormal bleeding, Uterine fibroids, Polyps, and many other fertility disorders are becoming common but so is the importance of getting rid of these problems. GenWorks works tirelessly to ascertain that these disorders get reduced by introducing minimally invasive procedures. Hysteroscopy is one such simplified tissue removal system.
At present, the methods used for Hysteroscopy include Resectoscopy – An electrical resection that causes scarring, abnormal bleeding, gas embolism, perforation, etc. Another method for the hysteroscopy process is blind D&C which includes supplying a high-frequency electrical current for intrauterine abnormality treatment causing scarring, abnormal bleeding, gas embolism, bowel perforation, etc. This is a blind procedure and 87% of the lesions remain after this procedure. With an aim to make the hysteroscopic procedure minimally invasive and completely simple, GenWorks introduces Mechanical Hysteroscopic Tissue Removal System that uses a simple mechanical approach for removing intrauterine tissues.